Search
Search Results
##search.searchResults.foundPlural##
-
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1500PDF: 928Suppl. Files: 463HTML: 266 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1693PDF: 575HTML: 321 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2814PDF: 920HTML: 258 -
-
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
3255PDF: 986HTML: 3149flowcytometric result of peripheral blood sample: 187 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2521PDF: 803HTML: 1743 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2827PDF: 1149HTML: 3300 -
Pseudo-differentiation syndrome
1406PDF: 681HTML: 10855Figure 1: peripheral blood showing myeloblasts with auer rods: 128Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 112Figure 3: CXR showing pulmonary infiltartes with consolidation: 140Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 123Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 122 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2925PDF: 874HTML: 6560Untitled: 252Untitled: 204Untitled: 226Untitled: 232 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2863PDF: 1851HTML: 3703Pellagatti Fig 1: 228Pellagatti Fig. 2: 221 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1865PDF: 1014HTML: 172 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
967PDF: 530HTML: 217 -
Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
2058PDF: 940HTML: 1774Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 178 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1830PDF: 840HTML: 207 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1216PDF: 775HTML: 1508Figure 1: 200Figure 2: 201 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
772PDF: 894PDF Supp. Files: 81HTML: 215 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3644PDF: 1545HTML: 4460CoverLetter: 193Figure1: 204 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1863PDF: 931HTML: 991Referring article: 759 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1222PDF: 754Html: 108 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2089PDF: 786HTML: 3174 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13308PDF: 994HTML: 7300







